Developing an intervention for HIV, hepatitis C, and opioid use among people who inject drugs along the Texas-Mexico border
Official title: Proyecto Vida: Developing an HIV, HCV and opioid use MOST intervention for persons who inject drugs along the Texas-Mexico Border
Funded at University of California, San Francisco · NIH-11085858 · Data updated 2026-11-12
This study is working to find the best ways to help Latino people in Ciudad Juárez who use drugs and are dealing with HIV and hepatitis C by testing different support options like peer guidance, HIV testing, and safe syringe services to improve their health and well-being.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 30, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $184,613 |
| NIH project number | 1K01DA062564-01 |
| Project ID | NIH-11085858 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Latino individuals who inject drugs and live along the Texas-Mexico border, particularly in underserved areas like Ciudad Juárez.
✕Less likely to help
Patients who do not inject drugs or those living outside the targeted geographic area may not benefit from this research.
What this research studies
This research focuses on creating a comprehensive intervention to address the intertwined issues of HIV, hepatitis C (HCV), and opioid use among Latino individuals who inject drugs in Ciudad Juárez, Mexico. The project employs a multiphase optimization strategy (MOST) to develop and test various intervention components, including peer navigation for HCV treatment, HIV testing and education, opioid agonist treatment, and syringe services. By optimizing these components, the research aims to improve health outcomes and reduce the prevalence of these conditions in a high-risk population. The study will also involve assessing the feasibility and acceptability of these interventions through a factorial experiment.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of HIV and HCV among people who inject drugs, improving overall health and quality of life for this vulnerable population.
How similar studies have gone: Previous research has shown success in using similar intervention strategies to address HIV and HCV among high-risk populations, indicating potential for positive outcomes in this study.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Ludwig-Barron, Natasha — University of California, San Francisco
- Study coordinator: Ludwig-Barron, Natasha
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.